First Time Loading...

Shandong Xinhua Pharmaceutical Co Ltd
SZSE:000756

Watchlist Manager
Shandong Xinhua Pharmaceutical Co Ltd Logo
Shandong Xinhua Pharmaceutical Co Ltd
SZSE:000756
Watchlist
Price: 15.7 CNY 0.38% Market Closed
Updated: Apr 29, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Shandong Xinhua Pharmaceutical Co Ltd

Wall Street analysts forecast Shandong Xinhua Pharmaceutical Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shandong Xinhua Pharmaceutical Co Ltd is 13.95 CNY .

Lowest Forecast
Wall Street Target
Not Available
Average Forecast
Wall Street Target
13.95 CNY
11% Downside
Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
13.95 CNY
11% Downside
Highest
Price Target
Not Available
Shandong Xinhua Pharmaceutical Co Ltd Competitors:
Price Targets
LUPIN
Lupin Ltd
15% Downside
ARVN
Arvinas Inc
123% Upside
B
600085
Beijing Tongrentang Co Ltd
41% Upside
VLS
Vita Life Sciences Ltd
62% Downside
LUPIN
Lupin Ltd
15% Downside
ARVN
Arvinas Inc
123% Upside
B
600085
Beijing Tongrentang Co Ltd
41% Upside
VLS
Vita Life Sciences Ltd
62% Downside
033270
Korea United Pharm Inc
51% Upside
C
060590
CTC Bio Inc
221% Upside
CLSD
Clearside Biomedical Inc
319% Upside
93M1
MPH Health Care AG
122% Upside

Revenue
Forecast

Revenue Estimate
Shandong Xinhua Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Shandong Xinhua Pharmaceutical Co Ltd's revenue is 11%. The projected CAGR for the next 6 years is -9%.

11%
Past Growth
-9%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Shandong Xinhua Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Shandong Xinhua Pharmaceutical Co Ltd's operating income is 18%. The projected CAGR for the next 6 years is -11%.

18%
Past Growth
-11%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Shandong Xinhua Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Shandong Xinhua Pharmaceutical Co Ltd's net income is 25%. The projected CAGR for the next 6 years is -12%.

25%
Past Growth
-12%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shandong Xinhua Pharmaceutical Co Ltd's stock price target?
Price Target
13.95 CNY

According to Wall Street analysts, the average 1-year price target for Shandong Xinhua Pharmaceutical Co Ltd is 13.95 CNY .

What is Shandong Xinhua Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
-9%

For the last 8 years the compound annual growth rate for Shandong Xinhua Pharmaceutical Co Ltd's revenue is 11%. The projected CAGR for the next 6 years is -9%.

What is Shandong Xinhua Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
-11%

For the last 8 years the compound annual growth rate for Shandong Xinhua Pharmaceutical Co Ltd's operating income is 18%. The projected CAGR for the next 6 years is -11%.

What is Shandong Xinhua Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
-12%

For the last 8 years the compound annual growth rate for Shandong Xinhua Pharmaceutical Co Ltd's net income is 25%. The projected CAGR for the next 6 years is -12%.

ALPHA SPREAD
Join more than 132,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.